What patient factors predict success with pharmacotherapy for smoking cessation?

• A. Motivation, confidence, prior quit attempts, readiness to change, social support, nicotine dependence level, adherence
• B. Age and gender only
• C. Geographic location
• D. Economic status

Answer: (A)

Successful smoking-cessation pharmacotherapy hinges on patient-driven factors that shape how effectively someone engages with treatment and manages withdrawal. Motivation to quit provides the drive to start and persist with medications; confidence or self-efficacy helps the patient cope with cravings and use the meds correctly, boosting adherence. Prior quit attempts offer practical lessons about what strategies work and what doesn’t, informing the current plan. Readiness to change reflects where the person is in the quitting process, and those more prepared tend to engage more fully with pharmacotherapy. Social support offers encouragement, accountability, and practical help, which enhances adherence and coping. Nicotine dependence level guides the intensity of cravings and dosing considerations, influencing how robust the treatment needs to be. Ultimately, adherence to the prescribed pharmacotherapy is essential for the meds to work. While demographic factors can affect access or context, they don’t predict success with pharmacotherapy as directly as these patient-centered factors.